IDO-1 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IDO-1 inhibitor, covering 2026-01-26 to 2026-01-26. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of IDO-1 Inhibition in the Prevention of EBV-related Pathology in EBV Negative Kidney Transplant Recipients Receiving an Organ From EBV Positive Donors [Phase 2]